Cargando…
Chir99021 and Valproic acid reduce the proliferative advantage of Apc mutant cells
More than 90% of colorectal cancers carry mutations in Apc that drive tumourigenesis. A 'just-right' signalling model proposes that Apc mutations stimulate optimal, but not excessive Wnt signalling, resulting in a growth advantage of Apc mutant over wild-type cells. Reversal of this growth...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5833359/ https://www.ncbi.nlm.nih.gov/pubmed/29449562 http://dx.doi.org/10.1038/s41419-017-0199-9 |